Position in TMO
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$11,029
-$2,242 QoQ
Shares Held
22
-18.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#2,526
of 2,602 holders
Holding Since
Mar 2023
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026DecisionPoint Financial, LLC holds $28,481 across 18 Diagnostics & Research names. TMO ranks #1 (38.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
22 | $11,029 | |
| 2 | DHR |
Danaher Corp /De/
|
49 | $9,333 | |
| 3 | A |
Agilent Technologies, Inc.
|
8 | $1,062 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
2 | $1,059 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
2 | $1,052 | |
| 6 | NTRA |
Natera, Inc.
|
3 | $814 | |
| 7 | WAT |
Waters Corp /De/
|
2 | $750 | |
| 8 | DGX |
Quest Diagnostics Inc
|
3 | $635 |
All Filings in TMO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,029 | 22 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $13,271 | 27 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $15,645 | 27 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $3,395 | 7 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,838 | 7 | Shares | Sole | 2025-08-14 | |
| 2023-03-31 | $11,527 | 20 | Shares | Sole | 2023-09-26 | |
| No filing history on record for this holder in this stock. | ||||||